Cargando…

Naringin in Ganshuang Granule suppresses activation of hepatic stellate cells for anti‐fibrosis effect by inhibition of mammalian target of rapamycin

A previous study has demonstrated that Ganshuang granule (GSG) plays an anti‐fibrotic role partially by deactivation of hepatic stellate cells (HSCs). In HSCs activation, mammalian target of rapamycin (mTOR)‐autophagy plays an important role. We attempted to investigate the role of mTOR‐autophagy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Hongbo, Shi, Honglin, Ren, Feng, Chen, Dexi, Chen, Yu, Duan, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323881/ https://www.ncbi.nlm.nih.gov/pubmed/27687505 http://dx.doi.org/10.1111/jcmm.12994

Ejemplares similares

Deficiency of apoptosis-stimulating protein two of p53 promotes liver regeneration in mice by activating mammalian target of rapamycin
por: Shi, Hongbo, et al.
Publicado: (2018)

Clinical efficacy and safety of Ganshuang granules as an adjuvant treatment for chronic hepatitis B liver fibrosis: A protocol for systematic review and meta analysis
por: Zeng, Shaoqian, et al.
Publicado: (2020)

Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Su, Changtian, et al.
Publicado: (2022)

Augmenter of liver regeneration protects against carbon tetrachloride-induced liver injury by promoting autophagy in mice
por: Shi, Hongbo, et al.
Publicado: (2017)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway
por: Hu, Jinyuan, et al.
Publicado: (2023)

ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy
por: Lin, Minghua, et al.
Publicado: (2017)

Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway
por: Liu, Yan, et al.
Publicado: (2020)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling
por: Ren, Jiafa, et al.
Publicado: (2016)

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
por: Yang, Xiao-Mei, et al.
Publicado: (2022)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Mammalian Target of Rapamycin Complex 1 Suppresses Lipolysis, Stimulates Lipogenesis, and Promotes Fat Storage
por: Chakrabarti, Partha, et al.
Publicado: (2010)

Interleukin-1 as an Injury Signal Mobilizes Retinyl Esters in Hepatic Stellate Cells through Down Regulation of Lecithin Retinol Acyltransferase
por: Kida, Yujiro, et al.
Publicado: (2011)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

The C-type lectin COLEC10 is predominantly produced by hepatic stellate cells and involved in the pathogenesis of liver fibrosis
por: Zhang, Mengfan, et al.
Publicado: (2023)

Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II-induced hepatic stellate cells activation
por: Li, Shu, et al.
Publicado: (2020)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Advances on liver cell‐derived exosomes in liver diseases
por: Jiao, Yan, et al.
Publicado: (2020)

miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
por: Wei, Song, et al.
Publicado: (2019)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis
por: Xiong, Yuanguo, et al.
Publicado: (2023)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
por: Shi, Zhemin, et al.
Publicado: (2020)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Paxillin regulates liver fibrosis via actin polymerization and ERK activation in hepatic stellate cells
por: Hijazi, Nour, et al.
Publicado: (2023)

MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression
por: Ma, Liping, et al.
Publicado: (2018)

SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells
por: Zhong, Xiaolin, et al.
Publicado: (2020)

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021)

Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
por: Ying, Hanglu, et al.
Publicado: (2022)

Naringin regulates mitochondrial dynamics to protect against acetaminophen-induced hepatotoxicity by activating the AMPK/Nrf2 signaling pathway in vitro
por: Wu, Qiao, et al.
Publicado: (2022)

Regulation of Gene Expression in Hepatic Cells by the Mammalian Target of Rapamycin (mTOR)
por: Jimenez, Rosa H., et al.
Publicado: (2010)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN
por: Cao, Yuhan, et al.
Publicado: (2019)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kcl9ikum3s59s4uogiicqn1npp